The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
32
No.
34
September 29, 2006
- Advocates Ask Genentech To Release FDA Letter On Avastin For Breast Cancer.
- Community Oncology Alliance Attack On Republican Leadership Prompts Others To Declare: We Aren’t COA.
- Robert Young To Step Down As Fox Chase Cancer Center President in 2007.
- Starr Foundation Gives $100 Million To Form Cancer Consortium.
- NCI Funds Proteomic Technology Assessment Grants.
CCL
Vol.
29
No.
9
September 29, 2006
- Gene Therapy Alters Immune Cells For Treatment Of Advanced Melanoma
- SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma
- Long-Term Remissions Shown With Chemo Plus Radiation
- Raloxifene Protects Women At High or Low Risk of Disease
- Study Needs 23,000 Women Whose Sisters Have Cancer
- Tamoxifen: No Mortality Benefit For Most “High Risk” Women
- Breast Density As Important As Age In Determining Risk
- Ovariectomy Without HRT Increases Death Rate
- NCI-Approved Clinical Trials
TCL
Vol.
32
No.
37
October 20, 2006
- NCI’s Future Depends On Recruiting Youth to Careers in Science, NCI Director Says at His Swearing-In Ceremony.
- CMS Considering Regulatory Standards for Drug Company Bundling of Products.
- Former FDA Commissioner Lester Crawford Pleads Guilty to Filing False Reports About His Ownership of Stocks in Health, Food, Biotech Companies.
CCL
Vol.
29
No.
10
October 27, 2006
- Women With Early Breast Cancer Can Wait Up To 12-Weeks For Chemo, Study Finds
- SWOG Study To Test Predictive Value Of Circulating Tumor Cells In Breast Cancer
- ASCO Updates Guideline On Follow-Up Management
- Exercisers May Have Higher Breast Cancer Survival
- New Screening Tool Helps GP ID Hereditary BC Risk
- Genomic Tests Not Shown To Decrease Deaths, Improve Quality Of Life
- ASCO Updates Guideline On Use Of Tumor Markers
- Standard Surgical Protocol Improved Endometrial Staging
- Lilly Begins Phase III Trial Of Alimta In Extensive SCLC
- FDA Approves Avastin For Recurrent NSCLC
- NCI-Approved Clinical Trials
